A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Study Summary

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

Conditions

COVID-19 SARS-COV-2 Infection

Interventions / Drugs

BNT162b2 Vaccine Placebo

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment25500 participants

Primary Completion—

Lead SponsorBioNTech SE

Data Retrieved2026-04-11 02:55:25.057534+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.